Robert W. Baird started coverage on shares of AvePoint (NASDAQ:AVPT – Free Report) in a report issued on Monday morning, Marketbeat reports. The brokerage issued a neutral rating and a $17.00 price target on the stock.
AVPT has been the topic of a number of other research reports. B. Riley began coverage on shares of AvePoint in a research report on Tuesday, August 26th. They issued a “buy” rating and a $25.00 price target on the stock. Cantor Fitzgerald raised shares of AvePoint to a “strong-buy” rating in a research report on Friday, July 25th. Citigroup dropped their target price on shares of AvePoint from $19.00 to $18.00 and set a “neutral” rating on the stock in a research report on Monday, August 18th. Dbs Bank raised shares of AvePoint to a “moderate buy” rating in a research report on Monday, October 6th. Finally, DA Davidson assumed coverage on shares of AvePoint in a research report on Monday, September 22nd. They set a “buy” rating and a $20.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, AvePoint has a consensus rating of “Moderate Buy” and an average target price of $19.91.
Check Out Our Latest Report on AvePoint
AvePoint Stock Down 1.2%
Insider Activity
In other AvePoint news, CFO James Caci sold 216,000 shares of AvePoint stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $15.21, for a total transaction of $3,285,360.00. Following the sale, the chief financial officer owned 213,030 shares in the company, valued at $3,240,186.30. The trade was a 50.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Chairman Xunkai Gong sold 4,167 shares of AvePoint stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $15.08, for a total transaction of $62,838.36. Following the sale, the chairman owned 15,100,668 shares in the company, valued at $227,718,073.44. This represents a 0.03% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 5,693,932 shares of company stock valued at $86,624,872. 26.19% of the stock is owned by insiders.
Institutional Investors Weigh In On AvePoint
Institutional investors have recently bought and sold shares of the business. Global Retirement Partners LLC acquired a new stake in AvePoint during the third quarter worth $26,000. Summit Securities Group LLC boosted its stake in AvePoint by 621.7% during the first quarter. Summit Securities Group LLC now owns 2,627 shares of the company’s stock worth $38,000 after buying an additional 2,263 shares in the last quarter. Advisors Asset Management Inc. boosted its stake in shares of AvePoint by 68.4% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,263 shares of the company’s stock valued at $44,000 after purchasing an additional 919 shares in the last quarter. Quarry LP boosted its stake in shares of AvePoint by 2,028.3% in the 1st quarter. Quarry LP now owns 3,831 shares of the company’s stock valued at $55,000 after purchasing an additional 3,651 shares in the last quarter. Finally, KBC Group NV acquired a new stake in shares of AvePoint in the 1st quarter valued at $67,000. Institutional investors and hedge funds own 44.49% of the company’s stock.
AvePoint Company Profile
AvePoint, Inc provides cloud-native data management software platform in North America, Europe, Middle East, Africa, and Asia Pacific. It also offers software-as-a-service solutions and productivity applications. The company offers modularity and cloud services architecture to address critical challenges and the management of data to organizations that leverage third-party cloud vendors, including Microsoft, Salesforce, Google, AWS, Box, DropBox, and others; license and support; and maintenance services.
Featured Stories
- Five stocks we like better than AvePoint
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- 5 discounted opportunities for dividend growth investors
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- Why Are Stock Sectors Important to Successful Investing?
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.
